InspireMD ( NASDAQ:NSPR ) Full Year 2024 Results Key Financial Results Revenue: US$7.01m (up 13% from FY 2023). Net... InspireMD Inc (NSPR) reports a 10.6% revenue increase in Q4 2024, while ...
Lake Street analyst Frank Takkinen reiterated a Buy rating on InspireMD (NSPR – Research Report) today and set a price target of $5.00. The company’s shares opened today at $2.83. Effectively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback